首页> 外文学位 >Recognition of base mismatches in DNA by chrysenequinone diimine intercalators of rhodium(III).
【24h】

Recognition of base mismatches in DNA by chrysenequinone diimine intercalators of rhodium(III).

机译:铑(III)的苯醌二亚胺嵌入剂识别DNA中的碱基错配。

获取原文
获取原文并翻译 | 示例

摘要

The ability to recognize base mismatches in DNA is of interest both for application to the molecular diagnosis of genetic mutations and for the design of chemotherapeutic agents for diseases associated with failure of cellular mismatch repair. The design and synthesis of a family of transition metal complexes containing the novel chrysenequinone diimine (chrysi) intercalating ligand is described. This sterically bulky intercalating ligand was designed to preferentially bind to the destabilized regions of DNA introduced by most base mismatches. One such compound, bis 2,2'-bipyridine chrysenequinone diimine rhodium(III) ([Rh(bpy)2(chrysi)] 3+), has been shown to be a broadly specific mismatch recognition agent which binds and, upon photo-activation, cleaves DNA at or near 82% of the 128 possible three base pair DNA sequences containing a central mismatched base. The cleavage of DNA at individual sites has been shown to be broadly correlated with the helix destabilization caused by the mismatch although it is clear that many factors can affect both the binding affinity and efficiency of its photocleavage chemistry from site to site.; [Rh(bpy)2(chrysi)]3+ has also been demonstrated to be exquisitely specific. Binding constants at some mismatch sites were found to be as high as 2 x 107 M--1 compared to an association constant of 4 x 104 M--1 to B-form DNA. This level of specificity was sufficient to allow discrimination of a single base mismatch in a 2725 base pair plasmid heteroduplex. The study of these compounds also led to the discovery that some mono-quinone diimine complexes of rhodium(III) can photocatalytically cleave DNA when irradiated with visible light. Such a property could be advantageous in the design of photodynamic therapy agents based on these compounds. Preliminary experiments and progress towards the elucidation of the mechanism of this photocatalytic cleavage is also described.; In addition to the application of chrysi complexes to mismatch recognition, novel methods for the synthesis of these compounds based on the condensation of aromatic quinones with ammine ligands on rhodium(III) are also reported. Methodology for the quantitative measurement of thermodynamic binding constants for molecules which bind and cleave nucleic acids are also discussed.
机译:识别DNA中碱基错配的能力不仅对应用于遗传突变的分子诊断,而且对于与细胞错配修复失败相关的疾病的化学治疗剂的设计都非常重要。描述和过渡金属配合物家族的设计和合成,其中包含新型的苯醌二亚胺(chrysi)嵌入配体。这种空间上庞大的嵌入配体被设计为优先结合大多数碱基错配引入的DNA不稳定区域。一种这样的化合物,即双2,2'-联吡啶苯醌二亚胺铑(III)([Rh(bpy)2(chrysi)] 3+),是一种广泛特异性的错配识别剂,可与光子结合,激活后,可在包含中央错配碱基的128个可能的三个碱基对DNA序列中的82%处或附近切割DNA。已经表明,在单个位点的DNA切割与由错配引起的螺旋失稳具有广泛的相关性,尽管很明显,许多因素会影响其结合亲和力以及从位点到位点的光切割化学的效率。 [Rh(bpy)2(chrysi)] 3+也被证明非常精确。与4×104 M--1与B型DNA的缔合常数相比,发现某些错配位点的结合常数高达2 x 107 M--1。这种特异性水平足以区分2725个碱基对的质粒异源双链中的单个碱基错配。对这些化合物的研究还导致人们发现,铑(III)的某些单醌二亚胺配合物在可见光照射下可以光催化裂解DNA。这种性质在基于这些化合物的光动力治疗剂的设计中可能是有利的。还描述了初步实验和阐明这种光催化裂解机理的进展。除了将晶体配合物用于错配识别外,还报道了基于芳族醌与氨基配体在铑(III)上缩合的合成这些化合物的新方法。还讨论了定量测量结合和切割核酸的分子的热力学结合常数的方法。

著录项

  • 作者

    Jackson, Brian Anthony.;

  • 作者单位

    California Institute of Technology.;

  • 授予单位 California Institute of Technology.;
  • 学科 Health Sciences Pharmacology.; Chemistry Biochemistry.; Chemistry Inorganic.
  • 学位 Ph.D.
  • 年度 1999
  • 页码 538 p.
  • 总页数 538
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号